Oral Corticosteroids for Post-infectious Cough in Adults
Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether a 5-day treatment with orally administered
prednisone provides patient-relevant benefits by improving the cough-related QoL of patients
with post-infectious cough triggered by an Upper Respiratory Tract Infection (URTI) and
seeking care in adult primary care practices. The study aims to describe an efficacy and
safety profile for a 5-day prednisone treatment compared to a 5-day course of placebo.